SUMMARY Serum ferritin, liver iron stores, and liver histology were studied in 38 children with thalassaemia major who were being treated by regular blood transfusions. There was no correlation between serum ferritin levels and either the number of transfusions or the amount of iron deposited in the liver. However, for a given level of iron stores, ferritin levels were higher in patients with chronic hepatitis (including chronic aggressive and chronic persistent forms) than in those with hepatic siderosis only. We conclude that serum ferritin reflects tissue iron deposits in regularly transfused thalassaemic patients, only in the absence of hepatitis. 
Many authors have shown that serum ferritin concentration reflects body iron stores.1-2 Moreover there is a direct correlation between the units of blood transfused and serum ferritin levels in patients with transfusion siderosis.2-3 On the other hand, Lipschitz et al.2 and Prieto et al. 4 found raised serum ferritin levels in patients with both acute and chronic hepatitis, the values being particularly high in patients with viral hepatitis or drug-induced liver necrosis. Jacobs5 stated that there were insufficient data for using serum ferritin as an index for liver injury. Therefore, the use of ferritin determinations clinically should be confined to providing a simple and noninvasive way to evaluate body iron stores.
Earlier studies (unpublished) showed, as did the findings of Masera et Liver biopsy tissue is cut in two: one part is used for histopathology. The iron content of the other is determined as follows: the dry sample is incinerated in a muffle oven at 600°C; the ashes are dissolved in 3 ml concentrated HCI and brought to 100 ml with deionised H20. Iron-free glassware and solutions are used throughout. A Perkin-Elmer model 503 spectrophotometer with atomic absorption is used for iron determination; the flame technique is followed for iron solutions >0 1 mg/l and the graphite oven technique (using model HGA 2100) for lower concentrations.
The patient's serum obtained just before liver biopsy is used for serum iron determination. Serum ferritin concentration is measured in duplicate samples of venous blood as ferritin protein using the immunoradiometric assay technique of Addison et al.11 modified by Miles et al.12
Results Fig. 1 shows the serum ferritin levels related to the number of transfusions the patients received (units of blood transfused). There was no correlation between serum ferritin levels and the number of transfusions received, even in cases of simple siderosis (r=0'176; P=NS). Fig. 2 shows serum ferritin levels in patients with differing liver histopathology: there was a highly significant difference (P<0 001) between the mean serum ferritin level in patients with simple siderosis compared with those with CPH and CAH. Moreover patients with CAH had higher levels than those with CPH (P<0 001), while there was no significant difference between patients with simple siderosis and those with CPH. 
Discussion
We found no correlation between serum ferritin levels and either the number of transfusions received, or the amount of liver iron in patients with thalassaemia major and chronic hepatitis. This is contrary to the findings of Letsky et al. 3 One reason for this might be that our patients had had irregular and low transfusions before this 3-year study, perhaps leading to an irregular and high intestinal absorption of iron. A second explanation might be that our patients had not all followed the chelation treatment with desferrioxamine in the same way. However, these explanations scarcely account for the lack of correlation between serum ferritin and liver iron. Yet if liver histopathology is also taken into account, with an equal iron concentration in the liver, serum ferritin levels are significantly higher in patients with CAH and CPH than in those with simple liver siderosis. In our patients with chronic hepatitis, serum ferritin levels did not seem to reflect iron overload. There may be two reasons for these high levels: (1) Leakage from the injured liver cells. Prieto et al.4 studied a group of patients with acute and chronic liver diseases and found the highest ferritin levels in patients with massive liver necrosis. (2) Increased ferritin synthesis. Such an increase was found by Konijn and Hershko13 when they injected rats with turpentine.
Our data show that serum ferritin levels reflect body iron stores only in regularly transfused patients in whom there has been no acute or chronic hepatitis. The only other method to evaluate body iron stores is by way of a liver biopsy specimen.
In any event, when serum ferritin is greatly increased, whatever the reason, there is cause for concern and increasingly aggressive iron chelation treatment should be given.
We are grateful to Vera Pegna who translated the paper, and to Rita Loi for editorial assistance. 
